INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

Novel GLP-1 Cut Heavy Drinking Days in Alcohol Use Disorder

Save Like Comments Compare coverage
Image from Medpagetoday

Summary

(MedPage Today) -- The investigational glucagon/GLP-1 dual receptor agonist pemvidutide significantly reduced the number of heavy drinking days (HDDs) per week in patients with moderate-to-severe alcohol use disorder (AUD), the phase II RECLAIM...

Description from Medpagetoday.

Who is covering this

  1. Medpagetoday Center Factuality: Mostly factual US
    Novel GLP-1 Cut Heavy Drinking Days in Alcohol Use Disorder

    (MedPage Today) -- The investigational glucagon/GLP-1 dual receptor agonist pemvidutide significantly reduced the number of heavy drinking days (HDDs) per week in patients with moderate-to-severe alcohol use disorder (AUD), the phase II RECLAIM...

Comments

Comments need JavaScript.